Filana Therapeutics, Inc.
MX ˙ BMV ˙ US14817C1071
SecurityMX:FLNA / Filana Therapeutics, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership149,194 shares
Latest Disclosed Value $ 252,138
Northern Trust Corp ownership in FLNA / Filana Therapeutics, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 149,194 shares of Filana Therapeutics, Inc. (MX:FLNA) valued at $252,138 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 149,194 shares of Filana Therapeutics, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F FILANA THERAPEUTICS COM 14817C107 149,194 0 0.00 252 -14.58 0.0000
2026-02-17 2025-12-31 13F CASSAVA SCIENCES COM 14817C107 149,194 18,024 13.74 295 -22.57 0.0000
2025-11-14 2025-09-30 13F CASSAVA SCIENCES COM 14817C107 131,170 29,495 29.01 382 107.07 0.0000
2025-08-13 2025-06-30 13F CASSAVA SCIENCES COM 14817C107 101,675 -267,415 -72.45 184 -66.73 0.0000
2025-05-13 2025-03-31 13F CASSAVA SCIENCES COM 14817C107 369,090 -37,472 -9.22 554 -42.34 0.0001
2025-02-14 2024-12-31 13F CASSAVA SCIENCES COM 14817C107 406,562 10,782 2.72 959 -91.77 0.0001
2024-11-13 2024-09-30 13F CASSAVA SCIENCES COM 14817C107 395,780 17,437 4.61 11,648 149.29 0.0019
2024-08-14 2024-06-30 13F CASSAVA SCIENCES COM 14817C107 378,343 -475 -0.13 4,673 -39.21 0.0008
2024-05-14 2024-03-31 13F CASSAVA SCIENCES COM 14817C107 378,818 -8,848 -2.28 7,686 -11.92 0.0013
2024-02-13 2023-12-31 13F CASSAVA SCIENCES COM 14817C107 387,666 14,032 3.76 8,726 40.36 0.0016
2023-11-13 2023-09-30 13F CASSAVA SCIENCES COM 14817C107 373,634 2,996 0.81 6,217 -31.59 0.0012
2023-08-11 2023-06-30 13F CASSAVA SCIENCES COM 14817C107 370,638 10,215 2.83 9,088 4.54 0.0017
2023-05-15 2023-03-31 13F CASSAVA SCIENCES COM 14817C107 360,423 7,880 2.24 8,693 -16.53 0.0017
2023-02-13 2022-12-31 13F CASSAVA SCIENCES COM 14817C107 352,543 -394 -0.11 10,414 -29.44 0.0022
2022-11-14 2022-09-30 13F CASSAVA SCIENCES COM 14817C107 352,937 -5,409 -1.51 14,760 46.47 0.0034
2022-08-12 2022-06-30 13F CASSAVA SCIENCES COM 14817C107 358,346 -6,146 -1.69 10,077 -25.55 0.0022
2022-05-13 2022-03-31 13F CASSAVA SCIENCES COM 14817C107 364,492 -15,335 -4.04 13,536 -18.45 0.0024
2022-02-08 2021-12-31 13F CASSAVA SCIENCES COM 14817C107 379,827 -828 -0.22 16,598 -29.76 0.0027
2021-11-15 2021-09-30 13F CASSAVA SCIENCES COM 14817C107 380,655 146,291 62.42 23,631 18.02 0.0042
2021-08-13 2021-06-30 13F CASSAVA SCIENCES COM 14817C107 234,364 -105,957 -31.13 20,023 30.89 0.0035
2021-05-12 2021-03-31 13F CASSAVA SCIENCES COM 14817C107 340,321 -8,697 -2.49 15,298 542.77 0.0028
2021-02-11 2020-12-31 13F CASSAVA SCIENCES COM 14817C107 349,018 90,918 35.23 2,380 -19.89 0.0005
2020-11-16 2020-09-30 13F CASSAVA SCIENCES COM 14817C107 258,100 -6,671 -2.52 2,971 264.54 0.0007
2020-08-14 2020-06-30 13F CASSAVA SCIENCES COM 14817C107 264,771 228,613 632.26 815 450.68 0.0002
2020-05-14 2020-03-31 13F CASSAVA SCIENCES COM 14817C107 36,158 13,084 56.70 148 23.33 0.0000
2020-02-14 2019-12-31 13F CASSAVA SCIENCES COM 14817C107 23,074 5,390 30.48 120 471.43 0.0000
2019-11-13 2019-09-30 13F CASSAVA SCIENCES COM 14817C107 17,684 -1,000 -5.35 21 -8.70 0.0000
2019-08-13 2019-06-30 13F CASSAVA SCIENCES COM 14817C107 18,684 0 0.00 23 -4.17 0.0000
2019-05-13 2019-03-31 13F CASSAVA SCIENCES COM 14817C107 18,684 18,684 24 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.